Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03JFC
|
||||
Former ID |
DNC014111
|
||||
Drug Name |
3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530218] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H16N2O3
|
||||
Canonical SMILES |
CCCNC(=O)OC1=CC=CC(=C1)C2=NC3=CC=CC=C3O2
|
||||
InChI |
1S/C17H16N2O3/c1-2-10-18-17(20)21-13-7-5-6-12(11-13)16-19-14-8-3-4-9-15(14)22-16/h3-9,11H,2,10H2,1H3,(H,18,20)
|
||||
InChIKey |
VWTFAQPOTOAJGW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530218] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.